{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:14:50Z","timestamp":1792782890592,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"German Federal Institute for Drugs and Medical Devices (BfArM)","id":[{"id":"https:\/\/ror.org\/05ex5vz81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00228-017-2351-y","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T21:12:37Z","timestamp":1508793157000},"page":"171-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Drug safety in pregnancy: the German Embryotox institute"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8674-5817","authenticated-orcid":false,"given":"Katarina","family":"Dathe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"issue":"2","key":"2351_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/bdrc.21096","volume":"105","author":"N Vargesson","year":"2015","unstructured":"Vargesson N (2015) Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res C Embryo Today 105(2):140\u2013156. \nhttps:\/\/doi.org\/10.1002\/bdrc.21096","journal-title":"Birth Defects Res C Embryo Today"},{"key":"2351_CR2","unstructured":"Physicians\u2019 desk reference 71st ed. (2017). PDR network, Montvale, New Jersey, USA"},{"key":"2351_CR3","unstructured":"European Medicines Agency, CHMP (2008) Guideline on risk assessment of medicinal products on human reproduction and lactation: from data to labelling, EMEA\/CHMP\/203927\/2005, publication date 24\/07\/2008. \nhttp:\/\/www.ema.europa.eu"},{"key":"2351_CR4","unstructured":"Food and Drug Administration, content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling, publication date 09\/10\/2014. \nhttp:\/\/federalregister.gov\/a\/2014-28241"},{"issue":"3","key":"2351_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1474\u20134422(1012)70323-X","volume":"12","author":"KJ Meador","year":"2013","unstructured":"Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW (2013) Fetal antiepileptic drug exposure and cognitive outcomes at age 6\u00a0years (NEAD study): a prospective observational study. Lancet Neurol 12(3):244\u2013252. \nhttps:\/\/doi.org\/10.1016\/S1474\u20134422(1012)70323-X","journal-title":"Lancet Neurol"},{"issue":"1","key":"2351_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reprotox.2009.1002.1014","volume":"28","author":"A Ornoy","year":"2009","unstructured":"Ornoy A (2009) Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reprod Toxicol 28(1):1\u201310. \nhttps:\/\/doi.org\/10.1016\/j.reprotox.2009.1002.1014","journal-title":"Reprod Toxicol"},{"issue":"2","key":"2351_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S1474\u20134422(1015)00314\u201300312","volume":"15","author":"T Tomson","year":"2016","unstructured":"Tomson T, Battino D, Perucca E (2016) Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug. Lancet Neurol 15(2):210\u2013218. \nhttps:\/\/doi.org\/10.1016\/S1474\u20134422(1015)00314\u201300312","journal-title":"Lancet Neurol"},{"issue":"7","key":"2351_CR8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/epi.13021","volume":"56","author":"T Tomson","year":"2015","unstructured":"Tomson T, Marson A, Boon P, Canevini MP, Covanis A, Gaily E, Kalviainen R, Trinka E (2015) Valproate in the treatment of epilepsy in girls and women of childbearing potential. Epilepsia 56(7):1006\u20131019. \nhttps:\/\/doi.org\/10.1111\/epi.13021","journal-title":"Epilepsia"},{"key":"2351_CR9","unstructured":"European Medicines Agency (2014) PRAC recommends strengthening the restrictions on the use of valproate in women and girls, EMA\/612389\/2014, publication date 09\/10\/2014. \nhttp:\/\/www.ema.europa.eu\/ema\/"},{"key":"2351_CR10","unstructured":"European Medicines Agency PRAC (2014) Assessment report, substances related to valproate, EMA\/686022\/2014, publication date 09\/10\/2014. \nhttp:\/\/www.ema.europa.eu\/ema\/"},{"key":"2351_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2147\/DHPS.S50556","volume":"7","author":"RA Epstein","year":"2015","unstructured":"Epstein RA, Moore KM, Bobo WV (2015) Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges. Drug Healthc Patient Saf 7:7\u201329. \nhttps:\/\/doi.org\/10.2147\/DHPS.S50556\n\n eCollection 52015","journal-title":"Drug Healthc Patient Saf"},{"issue":"5","key":"2351_CR12","doi-asserted-by":"publisher","first-page":"e477","DOI":"10.4088\/JCP.4015r10483","volume":"78","author":"S Tosato","year":"2017","unstructured":"Tosato S, Albert U, Tomassi S, Iasevoli F, Carmassi C, Ferrari S, Nanni MG, Nivoli A, Volpe U, Atti AR, Fiorillo A (2017) A systematized review of atypical antipsychotics in pregnant women: balancing between risks of untreated illness and risks of drug-related adverse effects. J Clin Psychiatry 78(5):e477\u2013e489. \nhttps:\/\/doi.org\/10.4088\/JCP.4015r10483","journal-title":"J Clin Psychiatry"},{"issue":"23","key":"2351_CR13","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","volume":"362","author":"J Jentink","year":"2010","unstructured":"Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, de Jong-van den Berg LT (2010) Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 362(23):2185\u20132193. \nhttps:\/\/doi.org\/10.1056\/NEJMoa0907328","journal-title":"N Engl J Med"},{"issue":"14","key":"2351_CR14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJM198510033131401","volume":"313","author":"EJ Lammer","year":"1985","unstructured":"Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW Jr, Lott IT et al (1985) Retinoic acid embryopathy. N Engl J Med 313(14):837\u2013841","journal-title":"N Engl J Med"},{"issue":"10","key":"2351_CR15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1503\/cmaj.151243","volume":"188","author":"D Henry","year":"2016","unstructured":"Henry D, Dormuth C, Winquist B, Carney G, Bugden S, Teare G, Levesque LE, Berard A, Paterson JM, Platt RW (2016) Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy. CMAJ 188(10):723\u2013730. \nhttps:\/\/doi.org\/10.1503\/cmaj.151243","journal-title":"CMAJ"},{"issue":"11","key":"2351_CR16","doi-asserted-by":"publisher","first-page":"e005602","DOI":"10.1136\/bmjopen-002014-005602","volume":"4","author":"IM Zomerdijk","year":"2014","unstructured":"Zomerdijk IM, Ruiter R, Houweling LM, Herings RM, Sturkenboom MC, Straus SM, Stricker BH (2014) Isotretinoin exposure during pregnancy: a population-based study in The Netherlands. BMJ Open 4(11):e005602. \nhttps:\/\/doi.org\/10.1136\/bmjopen-002014-005602","journal-title":"BMJ Open"},{"issue":"4","key":"2351_CR17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0190-9622(92)70088-W","volume":"26","author":"WS Dai","year":"1992","unstructured":"Dai WS, LaBraico JM, Stern RS (1992) Epidemiology of isotretinoin exposure during pregnancy. J Am Acad Dermatol 26(4):599\u2013606","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2351_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00404\u201300009\u201301112-00402","volume":"281","author":"C Schaefer","year":"2010","unstructured":"Schaefer C, Meister R, Weber-Schoendorfer C (2010) Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy. Arch Gynecol Obstet 281(2):221\u2013227. \nhttps:\/\/doi.org\/10.1007\/s00404\u201300009\u201301112-00402","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"2351_CR19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/tera.1420500606","volume":"50","author":"M Barr Jr","year":"1994","unstructured":"Barr M Jr (1994) Teratogen update: angiotensin-converting enzyme inhibitors. Teratology 50(6):399\u2013409","journal-title":"Teratology"},{"issue":"3","key":"2351_CR20","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/j.1365\u20132125.2012.04388.x","volume":"75","author":"M Oppermann","year":"2013","unstructured":"Oppermann M, Padberg S, Kayser A, Weber-Schoendorfer C, Schaefer C (2013) Angiotensin-II receptor 1 antagonist fetopathy\u2014risk assessment, critical time period and vena cava thrombosis as a possible new feature. Br J Clin Pharmacol 75(3):822\u2013830. \nhttps:\/\/doi.org\/10.1111\/j.1365\u20132125.2012.04388.x","journal-title":"Br J Clin Pharmacol"},{"key":"2351_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.reprotox.2016.1006.1015","volume":"65","author":"K Dathe","year":"2016","unstructured":"Dathe K, Beck E, Schaefer C (2016) Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database. Reprod Toxicol 65:39\u201345. \nhttps:\/\/doi.org\/10.1016\/j.reprotox.2016.1006.1015","journal-title":"Reprod Toxicol"},{"issue":"2","key":"2351_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00392\u201300015\u201300893-00395","volume":"105","author":"M Hoeltzenbein","year":"2016","unstructured":"Hoeltzenbein M, Beck E, Meixner K, Schaefer C, Kreutz R (2016) Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre. Clin Res Cardiol 105(2):117\u2013126. \nhttps:\/\/doi.org\/10.1007\/s00392\u201300015\u201300893-00395","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"2351_CR23","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1160\/TH1116\u20131111-0838","volume":"117","author":"E Huttel","year":"2017","unstructured":"Huttel E, Padberg S, Meister R, Beck E, Schaefer C (2017) Pregnancy outcome of first trimester exposure to the vitamin K antagonist phenprocoumon depends on duration of treatment. Thromb Haemost 117(5):870\u2013879. \nhttps:\/\/doi.org\/10.1160\/TH1116\u20131111-0838","journal-title":"Thromb Haemost"},{"issue":"4","key":"2351_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/bcp.12642","volume":"80","author":"C Weber-Schoendorfer","year":"2015","unstructured":"Weber-Schoendorfer C, Oppermann M, Wacker E, Bernard N, Beghin D, Cuppers-Maarschalkerweerd B, Richardson JL, Rothuizen LE, Pistelli A, Malm H, Eleftheriou G, Kennedy D, Kadioglu Duman M, Meister R, Schaefer C (2015) Pregnancy outcome after TNF-alpha inhibitor therapy during the first trimester: a prospective multicentre cohort study. Br J Clin Pharmacol 80(4):727\u2013739. \nhttps:\/\/doi.org\/10.1111\/bcp.12642","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"2351_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/pds.3744","volume":"24","author":"E Wacker","year":"2015","unstructured":"Wacker E, Navarro A, Meister R, Padberg S, Weber-Schoendorfer C, Schaefer C (2015) Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome. Pharmacoepidemiol Drug Saf 24(4):353\u2013360. \nhttps:\/\/doi.org\/10.1002\/pds.3744","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2351_CR26","unstructured":"European surveillance of congenital anomalies EUROCAT (uploaded data 07\/04\/2017) Prevalence dat tables, cases and prevalence (per 10,000 births) of all congenital anomaly subgroups for all registries, from 2011\u20132015. In, \nhttp:\/\/www.eurocat-network.eu\/accessprevalencedata\/prevalencetables\n\n ed"},{"issue":"5","key":"2351_CR27","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/uog.12442","volume":"42","author":"A Borrell","year":"2013","unstructured":"Borrell A, Stergiotou I (2013) Miscarriage in contemporary maternal-fetal medicine: targeting clinical dilemmas. Ultrasound Obstet Gynecol 42(5):491\u2013497. \nhttps:\/\/doi.org\/10.1002\/uog.12442","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"2351_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1055\/s-0034-1385857","volume":"218","author":"M Voigt","year":"2014","unstructured":"Voigt M, Rochow N, Schneider KT, Hagenah HP, Scholz R, Hesse V, Wittwer-Backofen U, Straube S, Olbertz D (2014) New percentile values for the anthropometric dimensions of singleton neonates: analysis of perinatal survey data of 2007\u20132011 from all 16 states of Germany. Z Geburtshilfe Neonatol 218(5):210\u2013217. \nhttps:\/\/doi.org\/10.1055\/s-0034-1385857","journal-title":"Z Geburtshilfe Neonatol"},{"key":"2351_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.reprotox.2016.1011.1019","volume":"67","author":"E Beck","year":"2017","unstructured":"Beck E, Lechner A, Schaefer C (2017) Who seeks Teratology Information Service\u2019s advice? Assessing the risk of selection bias in observational cohort studies on drug risks in pregnancy. Reprod Toxicol 67:79\u201384. \nhttps:\/\/doi.org\/10.1016\/j.reprotox.2016.1011.1019","journal-title":"Reprod Toxicol"},{"issue":"1","key":"2351_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.reprotox.2008.1006.1006","volume":"26","author":"R Meister","year":"2008","unstructured":"Meister R, Schaefer C (2008) Statistical methods for estimating the probability of spontaneous abortion in observational studies\u2014analyzing pregnancies exposed to coumarin derivatives. Reprod Toxicol 26(1):31\u201335. \nhttps:\/\/doi.org\/10.1016\/j.reprotox.2008.1006.1006","journal-title":"Reprod Toxicol"},{"issue":"4","key":"2351_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/bdra.20658","volume":"88","author":"C Bower","year":"2010","unstructured":"Bower C, Rudy E, Callaghan A, Quick J, Nassar N (2010) Age at diagnosis of birth defects. Birth Defects Res A Clin Mol Teratol 88(4):251\u2013255. \nhttps:\/\/doi.org\/10.1002\/bdra.20658","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2351_CR32","unstructured":"Statistische \u00c4mter des Bundes und der L\u00e4nder Gebiet und Bev\u00f6lkerung - Fl\u00e4che und Bev\u00f6lkerung, 31\/12\/2015. In, \nhttp:\/\/www.statistik-portal.de\/Statistik-Portal\/de_jb01_jahrtab1.asp\n\n ed"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-017-2351-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2351-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2351-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T03:30:34Z","timestamp":1515641434000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-017-2351-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["2351"],"URL":"https:\/\/doi.org\/10.1007\/s00228-017-2351-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,24]]}}}